FDA approvals are increasing Medicare coverage, but it is still a long way from covering all recipients with obesity
Used during a defined recovery window, they are a high-leverage tool
Over 250 patients underwent metabolomics and lipidomic investigations, which revealed that unlike the baseline and placebo, tirzepatide, taken over 26 weeks, significantly impacted a group of lipids and metabolites like 3-hydroxybutyrate reduced branched-chain ketoacids (BCKA), branched-chain amino acids (BCAA), and direct catabolic products linked with obesity and insulin resistance
7 The side effects contribute to that number, but they arent the only issue
It acts on GLP-1 and GIP receptors
Enhances Joint Health: The regenerative properties of IGF-1 LR3 support healthy joints and connective tissues, reducing the wear and tear associated with physical activity and aging